Replimune Group, Inc.

REPL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2018
Assets
Cash & Equivalents $17.6M
Accounts Receivable —
Inventory —
Total Current Assets $64.7M
Property, Plant & Equipment $370.0K
Goodwill —
Intangible Assets (Excl. Goodwill) —
Total Assets $65.2M
Liabilities
Accounts Payable $2.0M
Total Current Liabilities $5.2M
Long-Term Debt —
Total Liabilities $6.9M
Stockholders' Equity
Retained Earnings $-28.9M
Total Stockholders' Equity $-28.1M
← Newer Page 2 of 2 Older →